AP NEWS

Research Report Identifies Diodes, Arbutus Biopharma, Radware, Immutep, Amarin, and SPS Commerce with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

June 6, 2018

NEW YORK, June 06, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Diodes Incorporated (NASDAQ:DIOD), Arbutus Biopharma Corporation (NASDAQ:ABUS), Radware Ltd. (NASDAQ:RDWR), Immutep Limited (NASDAQ:IMMP), Amarin Corporation PLC (NASDAQ:AMRN), and SPS Commerce, Inc. (NASDAQ:SPSC), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

DIOD DOWNLOAD: http://Fundamental-Markets.com/register/?so=DIOD ABUS DOWNLOAD: http://Fundamental-Markets.com/register/?so=ABUS RDWR DOWNLOAD: http://Fundamental-Markets.com/register/?so=RDWR IMMP DOWNLOAD: http://Fundamental-Markets.com/register/?so=IMMP AMRN DOWNLOAD: http://Fundamental-Markets.com/register/?so=AMRN SPSC DOWNLOAD: http://Fundamental-Markets.com/register/?so=SPSC

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Diodes Incorporated (NASDAQ:DIOD), Arbutus Biopharma Corporation (NASDAQ:ABUS), Radware Ltd. (NASDAQ:RDWR), Immutep Limited (NASDAQ:IMMP), Amarin Corporation PLC (NASDAQ:AMRN), and SPS Commerce, Inc. (NASDAQ:SPSC) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed June 1st, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

DIODES INCORPORATED (DIOD) REPORT OVERVIEW

Diodes’ Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Diodes reported revenue of $274.51MM vs $236.30MM (up 16.17%) and basic earnings per share $0.38 vs $0.03 (up 1,166.67%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Diodes reported revenue of $1,054.20MM vs $942.16MM (up 11.89%) and basic earnings per share -$0.04 vs $0.33. Diodes is expected to report earnings on August 14th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.36. The estimated EPS forecast for the next fiscal year is $2.05 and is expected to report on February 6th, 2019.

To read the full Diodes Incorporated (DIOD) report, download it here: http://Fundamental-Markets.com/register/?so=DIOD

-----------------------------------------

ARBUTUS BIOPHARMA CORPORATION (ABUS) REPORT OVERVIEW

Arbutus Biopharma’s Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Arbutus Biopharma reported revenue of $1.44MM vs $0.24MM (up 511.06%) and basic earnings per share -$0.36 vs -$0.34. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Arbutus Biopharma reported revenue of $10.70MM vs $1.49MM (up 617.64%) and basic earnings per share -$1.56 vs -$7.24. Arbutus Biopharma is expected to report earnings on August 2nd, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.28. The estimated EPS forecast for the next fiscal year is -$1.54 and is expected to report on March 13th, 2019.

To read the full Arbutus Biopharma Corporation (ABUS) report, download it here: http://Fundamental-Markets.com/register/?so=ABUS

-----------------------------------------

RADWARE LTD. (RDWR) REPORT OVERVIEW

Radware’s Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Radware reported revenue of $54.54MM vs $48.91MM (up 11.50%) and basic earnings per share -$0.02 vs -$0.09. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Radware reported revenue of $211.37MM vs $196.59MM (up 7.52%) and basic earnings per share -$0.17 vs -$0.20. Radware is expected to report earnings on August 1st, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.05. The estimated EPS forecast for the next fiscal year is $0.22 and is expected to report on February 6th, 2019.

To read the full Radware Ltd. (RDWR) report, download it here: http://Fundamental-Markets.com/register/?so=RDWR

-----------------------------------------

IMMUTEP LIMITED (IMMP) REPORT OVERVIEW

Immutep’s Recent Financial Performance

For the twelve months ended June 30th, 2017 vs June 30th, 2016, Immutep reported revenue of $3.18MM vs $1.48MM (up 115.29%) and basic earnings per share -$0.30 vs -$2.02.

To read the full Immutep Limited (IMMP) report, download it here: http://Fundamental-Markets.com/register/?so=IMMP

-----------------------------------------

AMARIN CORPORATION PLC (AMRN) REPORT OVERVIEW

Amarin’s Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Amarin reported revenue of $43.92MM vs $34.64MM (up 26.80%) and basic earnings per share -$0.08 vs -$0.08. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Amarin reported revenue of $181.10MM vs $130.08MM (up 39.22%) and basic earnings per share -$0.25 vs -$0.41. Amarin is expected to report earnings on August 1st, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.05. The estimated EPS forecast for the next fiscal year is $0.08 and is expected to report on February 26th, 2019.

To read the full Amarin Corporation PLC (AMRN) report, download it here: http://Fundamental-Markets.com/register/?so=AMRN

-----------------------------------------

SPS COMMERCE, INC. (SPSC) REPORT OVERVIEW

SPS Commerce’s Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, SPS Commerce reported revenue of $59.09MM vs $51.88MM (up 13.90%) and basic earnings per share $0.19 vs $0.17 (up 11.76%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, SPS Commerce reported revenue of $220.57MM vs $193.30MM (up 14.11%) and basic earnings per share -$0.14 vs $0.34. SPS Commerce is expected to report earnings on July 26th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.15. The estimated EPS forecast for the next fiscal year is $1.20 and is expected to report on February 5th, 2019.

To read the full SPS Commerce, Inc. (SPSC) report, download it here: http://Fundamental-Markets.com/register/?so=SPSC

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world’s leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers (“Registered Members”) working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

AP RADIO
Update hourly